Cure Parkinson's news

Prioritising the most promising drugs for Parkinson’s: our new drug screening project

Cure Parkinson’s is excited to announce funding for a pre-clinical project that aims to test, evaluate and compare drugs that have the potential to slow Parkinson’s progression. Established by Cure Parkinson’s, in collaboration with Van Andel Institute (VAI), the International Linked Clinical Trials (iLCT) committee…


News Fundraising news

Limited edition album ‘Think Loud’ to support Cure Parkinson’s

Music legends from the worlds of rock and folk have come together to create an exclusive double album to help raise funds and awareness for Cure Parkinson’s. Kindred Spirit have teamed up with musicians including Leo Sayer, John Cooper Clarke and Richard Thompson to create…


News Fundraising news

Cure Parkinson’s Fundraising Heroes: December 2024

2024 was a phenomenal year of fundraising for Cure Parkinson’s, and we’d like to say a huge thank you to everyone who helped raise vital funds and awareness for our research! We can’t wait to see what you – our incredible supporters – will do…


News Research news

2025: Cure Parkinson’s research highlights from the last year and insights for the year ahead

2024 was another busy year for the research team at Cure Parkinson’s; from the results publication of the phase 2 clinical trial of lixisenatide to the funding of new pre-clinical projects, Cure Parkinson’s has not stopped in its mission to slow, stop or reverse Parkinson’s….


The road ahead: 2025 (part 1)

The first post at the start of each year on the SoPD website has traditionally tried to provide an overview or some context on where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  Previous editions of the “Road Ahead” posts have become dangerously overloaded, unwieldy, chaotic one-page beasts, […]